Literature DB >> 2040178

Self-administered daily subcutaneous recombinant human erythropoietin: an open randomised dose-finding study in ESRD patients receiving peritoneal dialysis.

A Slingeneyer1, B Faller, B Laroche, B Ehmer, C Mion.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2040178     DOI: 10.1159/000419526

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


× No keyword cloud information.
  1 in total

Review 1.  Controversies in determination of epoetin (recombinant human erythropoietin) dosages.

Authors:  P A Abraham; W L St Peter; K A Redic-Kill; C E Halstenson
Journal:  Clin Pharmacokinet       Date:  1992-06       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.